18 - 20 June, 2019 | Crowne Plaza Zurich, Zurich, Switzerland

Main Conference Agenda Day 1

8:30 am - 9:00 am Morning Coffee and Registration

8:55 am - 9:00 am Pharma IQ Welcome

9:00 am - 9:10 am Chairman's Opening Address

9:10 am - 9:50 am Analysing the Landscape of Illicit Trade in Global Medicine Supply

- Examine the role of governments, NGOs and the pharmaceutical manufacturers when tackling
the counterfeit pharmaceutical industry
- Discuss current global regulatory requirements and where regulations need to evolve
in order to address the developments in falsified medicines
- Analyse the impact of illicit pharmaceutical trade on patient safety, pharmaceutical growth
in regionalised markets and loss of revenue

9:50 am - 10:30 am Panel Discussion: Identifying and Addressing Global Trends in Illicit Pharmaceutical Trade

Managing the security of the global supply chain, and thus, the integrity of global pharmaceutical
trade, remains one of the biggest threats to both patient safety and pharmaceutical profitability.
The growing presence of fraudulent and counterfeit pharmaceutical products continues to undermine
the health and development of regional markets globally. Yet, with so many disparate global points
of weakness and potential attack, it is clear that there is no easy solution.

In this discussion, panelists will examine:
- The role of both public and private sectors in mitigating against illicit pharmaceutical trade
- Cross sector industry perspective on risk mitigation and anti-counterfeit strategies
- Global awareness campaigns and the correlation with pharma industry activities: How can we align messaging and activity, and will it generate greater impact?

10:30 am - 11:00 am Morning Coffee Break

11:00 am - 11:40 am Regionalising the Pharmaceutical Supply Chain: Cause and Effect Analysis of Falsified Trade Proliferation With Reference to African Regulatory Harmonisation

- Investigate the changing nature of global pharmaceutical supply, and the pressure on global
patient safety and regional supply chain security
- Understand and mitigating the risks: Working with the public sector and donors to harmonise
regulations in the African regions
- Considerations for complex supply networks across borders: Why supporting organisations such as
the World Bank in their regional projects can result in stronger supply chains and minimise patient risk

11:40 am - 12:40 pm Interactive Workshop: What is Holding Us Back? Identify Your Supply Chain Bottle-Necks and Risks

This interactive session is focused on enabling the pharmaceutical sector to identify and address
the root causes and commonalities of illicit trade and subsequently, to more actively engage in
anti-illicit trade activities.

Focus areas of discussion include:
- Mode of drug transport and carrier selection: Air, sea freight and land transport
- Proliferation of e-commerce platforms and internet exposure
- Global customs and boarder navigation
- Free-zones: To what extent do regulatory differences affect trade in nearby markets
- Impact of organised crime on supply chain securitisation

12:40 pm - 1:40 pm Networking Lunch

1:40 pm - 2:20 pm Coordinating for Success: Structuring Your Product Security Strategies and Departments

- Examine the internal team structure required to generate a holistic brand protection strategy: Why cross department collaboration is integral to program success
- Discuss how to define your KPIs and critical success factors for an effective internal anti-counterfeit strategy
- Empower your teams through program impact measurements: How to convey program aims and requirements internally to maximise buy-in and utilise cross-function expertise

2:20 pm - 3:00 pm Public Sector Collaboration and Partnerships for Combating Illicit Pharmaceutical Trade: Why Should it Matter to You?

- Examining industry perceptions of pharma drug supply, and why it matters for the success
of private sector anti-counterfeit activities
- Define the role of NGOs and trade associations in influencing pharma specific regulations
to ensure you are maximising engagement opportunities
- Analyse the impact of public and private sector collaboration in regional anti-counterfeit programs

3:00 pm - 3:40 pm The Continued Threat of Substandard Medicines in Global Pharmaceutical Supply

- Identify the prevalence of substandard medicines in global supply, with a focus on substandard generics
- Quantify the potential impact to brand reputation and patient safety with reference to existing case studies
- Discuss methods for identifying of substandard medicines across your supply chain
- Recommendations for pharmaceutical manufacturers in reducing substandard medicines prevalence

3:40 pm - 4:10 pm Afternoon Coffee Break

4:10 pm - 5:10 pm Interactive Brand Protection and Anti-Counterfeit Discussion Groups

1. Globalisation of the supply chain: How to be vigilant in an ever connected global market

2. Securitisation beyond serialisation: How can we further leverage our serialisation implementation
Ifigenia Dimitriadou, Senior Manager, Serialisation and Logistics, Celgene

3. Control and visibility of supply chain regionalisation: Moving beyond regulatory compliance
and into prevention
Mark Willis, MDR and Compliance, Johnson & Johnson

4. Creating a proactive risk management strategy as a basis for your anti-counterfeiting strategy
Sven Bergmann, Managing Partner, Venture Global & Senior Advisor Anti-Illicit Trade,
The Partnership for Safe Medicines

5:10 pm - 5:50 pm Future of Anti-Counterfeiting for the Pharma Industry: Streamlining With Big Data and Emergent Technologies

- Discuss the value in utilising a data driven approach to identify your supply chain and product security weaknesses
- Identify regional and timing trends in illicit supply chain activity to ensure your mitigation strategy is targeted towards your biggest threats
- Build a risk map of company activities and capabilities as the basis of defining your key measurement and improvement metrics for anti-counterfeit activities

5:50 pm - 6:00 pm Chairman's Summary of Day 1